chemotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
chemotherapy
Jul 25, 2024, 21:01 |
Blog
Caner Saygin: A testament to the fact that flow MRD is insufficient for making treatment decisions in ALL
Caner Saygin, Assistant Professor of Medicine at University of Chicago, shared a post by NEJM, on X:…
Jul 25, 2024, 00:18 |
Blog
Breaking Science in Gastrointestinal Cancers with Kohei Shitara - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "For ESMO members: Breaking Science in Gastrointestinal…
Jul 24, 2024, 03:52 |
Insight
Piotr Wysocki: The type of immunotherapy-related adverse event impacts the outcomes of anti-cancer immunotherapy
Piotr Wysocki recently posted on LinkedIn: “Understanding the co-occurrence patterns of immune-related adverse events (irAEs) across…
Jul 24, 2024, 02:45 |
Blog
Mark Lewis: Treatment almost always has to be tolerable for it to be effective
Mark Lewis shared a post on X by Mark Cuban, Entrepreneur owner of Cost Plus…
Jul 22, 2024, 23:10 |
Blog
Edgardo S. Santos: The ProPhet test could help us to tailor immunotherapy beyond just PD-L1 expression
Edgardo S. Santos, Vice President of Florida Society of Clinical Oncology, shared a post on…
Jul 22, 2024, 16:08 |
Stories
Too many kids are dying from the side effects of traditional chemotherapy - Children’s Cancer Institute
Children’s Cancer Institute shared on LinkedIn: "Toby was still in his mother’s womb when doctors…
Jul 21, 2024, 16:40 |
Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 20, 2024, 12:06 |
Blog
Andrew Lane: Powerful segment produced by Medical Stories on one of my brave patients at Dana-Farber with BPDCN
Andrew Lane, Associate Chief of Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, shared a post…
Jul 20, 2024, 11:34 |
Blog
Abhishek D. Garg: TIM3+VISTA+ macrophage subset that mediates resistance to anticancer immunotherapy and chemotherapy
Abhishek D. Garg, Head of Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Jul 19, 2024, 23:00 |
Blog
Voice of the families. Tigist and her father - CANCaRe Africa
CANCaRe Africa shared a post on LinkedIn: ''Voice of the families. Post #13: Tigist and…
Jul 19, 2024, 13:20 |
Blog
Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…
Jul 19, 2024, 10:12 |
Insight
Michael Douglas: The Untold Story of His Battle Against Cancer
Michael Douglas, says “My cancer has made me a free man.” Thirteen years after surviving…
Jul 19, 2024, 08:42 |
Blog
Breaking Science in Gastrointestinal Cancers with Maximiliano Gelli - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "For ESMO members:…
Jul 15, 2024, 01:58 |
Stories
No one is too young to have cancer - Stella H.
Colorectal Cancer Alliance shared on LinkedIn: "'A lot of people still think colorectal cancer is…
Jul 14, 2024, 05:19 |
Blog
What 99% of people don't know about Colorectal Cancer
Hello, welcome to our course on colorectal cancer. In this video, we'll provide an overview…
Jul 13, 2024, 20:21 |
Blog
Antoni van Leeuwenhoek has been awarded with grant of 4.1 million eur
Marleen Kok shared Antoni van Leeuwenhoek's post on LinkedIn, adding: "Incredibly proud of my team…
Jul 13, 2024, 14:15 |
Dialogues
I never knew how close to this disease I would eventually become - Benny Johnson’s personal story with cancer
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr.…
Jul 11, 2024, 17:37 |
Blog
Myriam Chalabi: An important international study on whether high TILs can be used to safely omit chemotherapy in TNBC
Myriam Chalabi shared a post by The Netherlands Cancer Institute, on X, adding: ''Congratulation Marleen Kok…
Jul 11, 2024, 14:56 |
Insight
Simona Cristea: The multi-facet process of resistance to KRAS inhibitors in pancreatic cancer
Simona Cristea, Head of Data Science at Hale Center for Pancreatic Cancer, shared a post by…
Jul 11, 2024, 13:16 |
Blog
Steven O'Day about how immunotherapy stands apart from traditional chemotherapy - Agenus
Agenus shared a post on LinkedIn: . "Did you know immunotherapy activates the body’s own…
Jul 10, 2024, 05:38 |
Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
Jul 9, 2024, 09:41 |
Insight
Rebecca Shatsky: Love my good friend Paolo Tarantino’s explanation of Her2 Ultra Low
Rebecca Shatsky shared a post by Paolo Tarantino on X, adding: “Love my good friend Paolo…
Jul 8, 2024, 04:52 |
Insight
Spotlight on Alveolar soft part sarcoma - NCI
National Cancer Institute (NCI) shared a post on LinkedIn: "Alveolar soft part sarcoma (ASPS) is…
Jul 8, 2024, 01:07 |
Blog
Konstantinos Kokkaliaris: Niche-centric strategies to revert aging and chemotherapy-related hematopoietic decline
Konstantinos Kokkaliaris, Junior group leader at Dr. Senckenberg Institute of Pathology, shared a post on…
Jul 5, 2024, 16:12 |
Insight
Sunscreen Is Your Best Friend This Summer - Sylvester Cancer Experts
Feels good to soak up some rays by the beach or pool, but your skin…
Jul 4, 2024, 10:04 |
Blog
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…
Jul 3, 2024, 01:37 |
Blog
Albert Grinshpun: Another important sub-population which might enjoy life without chemo
Albert Grinshpun, Goldfarb Advanced Breast Cancer Fellow at the Breast Oncology Center of Dana-Farber Cancer…
Jul 2, 2024, 08:47 |
Insight
Lecture from CCLG UK on management of chemotherapy induced pain and nausea- POINTE
Pediatric Oncology International Network for Training and Education (POINTE) shared on X: “Paediatric Haematology/Oncology Online…
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 30, 2024, 16:30 |
Insight
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn: “Patients with stage…
Jun 29, 2024, 13:50 |
Drugs
Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer
Syed A. Ahmad, Chief of Surgical Oncology at The University of Cincinnati, made the following…
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 14:17 |
Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 27, 2024, 13:17 |
Insight
Non-chemotherapy treatment regimen for aggressive B-cell lymphoma
Kimryn Rathmell shared on X: "Exciting news: NCI researchers and collaborators have developed a non-chemotherapy…
Jun 25, 2024, 03:11 |
Blog
Eytan Ruppin: Analyzing Tumor Microenvironment using bulk transcriptomics with Machine Learning
Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health, shared…
Jun 25, 2024, 02:26 |
Blog
Carmen Uscatu: Compassion means empathy in action
Carmen Uscatu, President at Give Life, shared a post on LinkedIn: …
Jun 24, 2024, 22:56 |
Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 24, 2024, 13:43 |
Blog
Kids deserve less toxic treatments - St. Baldrick’s Foundation
St. Baldrick’s Foundation posted on LinkedIn: . “Birthdays are supposed to be a time…
Jun 24, 2024, 05:46 |
Blog
Trish Boh: The Dearborn Cancer Center
Trish Boh, Executive Secretary to Executive Medical Director of Oncology Services and Directors at St. Elizabeth…
Jun 22, 2024, 02:02 |
Blog
Sameh Abdelmalak: Dr. Giuseppe Curigliano discussing ASCO24 DESTINY-Breast06
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X: "Check out…
Jun 20, 2024, 16:00 |
Insight
Andrew Parsonson: Median pooled OS over 5 years for MBC on first line ET and CDK4/6
Andrew Parsonson, Medical Oncologist at Nepean Blue Mountains Local Health District (NBMLHD), shared a post…
Jun 20, 2024, 13:02 |
Stories
From full time patient to a physician- Colorectal Cancer Alliance
Colorectal Cancer Alliance shared a post on LinkedIn: “My name is Sachin. I am 41 years…
Jun 18, 2024, 16:21 |
Blog
Shahrin Ahmed: The use of heated drug baths can offer hope to patients with stomach cancer
Shahrin Ahmed, a Medical Specialist at the Canadian Cancer Society, made the following post on…
Jun 18, 2024, 07:07 |
Insight
Tislelizumab plus chemotherapy in advanced gastric/GEJ adenocarcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Tislelizumab plus chemotherapy vs…
Jun 17, 2024, 13:17 |
Cancer Types
Vulvar Cancer: What patients should know about
Introduction Vulvar cancer is a rare type of cancer that affects the external part of…
Jun 17, 2024, 12:53 |
Blog
Harold Burstein: Wishing Princess Catherine, and all cancer patients, good health and speedy recovery
Harold Burstein, Breast cancer specialist and professor at Dana-Farber Cancer Institute and Harvard Medical School,…
Jun 17, 2024, 01:34 |
Blog
Your messages of support and encouragement really has made a world of difference to us - The Prince and Princess of Wales
Mark Lewis shared a post by The Prince and Princess of Wales on X, adding:…
Jun 15, 2024, 15:29 |
Insight
Yüksel Ürün: Scalp cooling can significantly reduce long-term hair loss after chemotherapy
Yüksel Ürün shared on X: "Scalp cooling can significantly reduce long-term hair loss after chemotherapy..…
Jun 13, 2024, 06:29 |
Insight
Stephanie Otto: We can’t accept that some cancer patients still don’t have access to treatment as recommended
Stephanie Otto, Visiting Professor at Barceló Foundation, Senior Scientist and Exercise Oncologist at Ulm University…
Jun 12, 2024, 15:42 |
Cancer Types
Thymoma and Thymic Carcinoma: What patients should know about
Introduction The thymus is a small, butterfly-shaped organ located in the upper chest, just behind…
Jun 12, 2024, 03:30 |
Blog
Rasha Aboelhassan: Solving debates for the treatment of stage III inoperable lung cancer is challenging
Rasha Aboelhassan shared on LinkedIn: "For decades, solving debates for the treatment of stage III…
Jun 11, 2024, 10:50 |
Insight
9 out of 10 patients with CINV report an impact on their daily life - Chugai Pharma Europe
Chugai Pharma Europe shared on LinkedIn: “Did you know 9 out of 10 patients with…
Jun 11, 2024, 03:05 |
Cancer Types
Vaginal Cancer: What patients should know about
Introduction Vaginal cancer is a rare type of cancer that begins in the vagina. It…
Jun 9, 2024, 16:20 |
Insight
Sheheryar Kabraji: Look at how ER low tumors behave
Sheheryar Kabraji, Associate Professor at Roswell Park Comprehensive Cancer Center, shared on X/Twitter: "! Very cool…
Jun 8, 2024, 05:20 |
Insight
Mohammad Jad Moussa: ASCO24 Proceedings - GTA as a Nephron-Sparing 'Bridging' Strategy
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…
Jun 7, 2024, 11:00 |
Blog
Krishan Jethwa: ESOPEC practice shifting trial at ASCO24
Krishan Jethwa, Assistant Professor of Radiation Oncology at Mayo Clinic, shared on X: ''ESOPEC. Practice…
Jun 6, 2024, 16:10 |
Cancer Types
Langerhans Cell Histiocytosis: What patients should know about
What is Langerhans Cell Histiocytosis? Langerhans cell histiocytosis (LCH) is a rare disorder characterized by…
Jun 6, 2024, 13:18 |
Blog
María Natalia Gandur Quiroga on JAVELIN Renal 101 trial by Camillo Porta
María Natalia Gandur Quiroga shared on X/Twitter: ''In It for the Long Run: Updated Outcomes…
Jun 5, 2024, 12:51 |
Blog
Susan G. Komen: Tarah Ballinger presents results from the EAZ171 trial at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a…
Jun 4, 2024, 04:06 |
Blog
Jun Gong: Dr. Martijn Meijerink's Phase III COLLISION trial less than 10 colorectal liver metastases
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post…
Jun 4, 2024, 03:15 |
Blog
Nina Niu Sanford: Liver transplant and chemotherapy to colorectal cancer with unresectable liver metastasis
Nina Niu Sanford shared on X/Twitter: "TRANSMET: addition of liver transplant to chemotherapy in colorectal cancer…
Jun 3, 2024, 22:53 |
Insight
Paul Healy: AstraZeneca and Daiichi Sankyo have announced positive results from datopotamab deruxtecan in certain lung cancer patients
Paul Healy, Director of PHARMeMED, shared on LinkedIn: "AstraZeneca (AZ) and Daiichi Sankyo have announced positive…
Jun 3, 2024, 11:57 |
Societies
Tanja Obradovic: Very dynamic day at ASCO2024
Tanja Obradovic shared a post on LinkedIn: "Very dynamic ASCO2024 day as we learned quite…
May 31, 2024, 11:04 |
Blog
AACR - We recognize Waun Ki Hong the first Asian-American scientist to be elected President of the AACR (2001-2002)
AACR shared a post on LinkedIn: "May is Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage…
May 30, 2024, 14:32 |
Blog
Shahrin Ahmed: Be a stem cell donor and make a difference!
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: “May 28th…
May 30, 2024, 10:57 |
Insight
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer…
May 29, 2024, 12:27 |
Societies
Cristiane Bergerot: A study will be presented on June 3rd at ASCO24 by Renata Ferrari
Cristiane Bergerot recently shared on X: "This study will be presented on June 3rd at…
May 28, 2024, 11:38 |
Insight
Dr. Travis Grotz discusses how HIPEC works in stomach cancers - Mayo Clinic
Mayo Clinic recently shared a post on LinkedIn: "Mayo Clinic experts are exploring new ways…
May 28, 2024, 08:31 |
Blog
Gilberto Lopes: Press release just in time to make things more interesting for ASCO24
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a…
May 27, 2024, 07:37 |
Blog
Eric K. Singhi on BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo in 1L ES-SCLC
Eric K. Singhi shared the following on X: “BEAT-SC: Phase 3 Bev + Chemo/Atezo v Chemo/Atezo…
May 27, 2024, 04:19 |
Opinion
Gilberto Lopes: My top ASCO24 lung cancer abstracts!
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared…
May 27, 2024, 04:00 |
Blog
Diego Dibitetto: H2AX downregulation is a new mechanism of chemotherapy resistance in BRCA-deficient tumors
Diego Dibitetto, Postdoc fellow at the University of Bern, shared a post on LinkedIn: "Our new…
May 26, 2024, 16:38 |
Blog
Zouina Sarfraz: Two of my abstracts have been published for the 2024 ASCO Annual Meeting
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: "I am pleased to announce…
May 26, 2024, 02:20 |
Blog
Shahrin Ahmed: New treatment for a form of acute myeloid leukaemia approved for use on NHS - UK
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, made the following post on X: "Blood…
May 24, 2024, 09:10 |
Stories
William Floyd High School Unites in Honor of Rayna’s Fight Against Cancer - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: "Cara is a long-time volunteer who lost…
May 23, 2024, 09:20 |
Blog
Yakup Ergün Summarizes Final Results of RIGHT Choice
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:…
May 21, 2024, 15:36 |
Blog
To test or not to test this should be patient's decision - Advocates for Universal DPD/DPYD Testing
Advocates for Universal DPD/DPYD Testing shared a post by Ken Surprenanton, Advocate at DPD/DPYD, on…
May 21, 2024, 03:53 |
Blog
Roupen Odabashian: Why Machines or AI Can't Replace Physicians
Roupen Odabashian shared a post on LinkedIn: ''Why Machines or AI Can't Replace Physicians? Many people…
May 20, 2024, 14:44 |
Blog
Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer
Syed A. Ahmad, Director at University of Cincinnati Cancer Center & Chief of Surgical Oncology…
May 20, 2024, 11:06 |
Blog
Eslam Hamdy: We successfully executed two sessions of Merck Saudi Fertility ART Forum in both Riyadh and Jeddah
Eslam Hamdy, Franchise Manager at Merck, Saudi Arabia shared a post on LinkedIn: “Did you…
May 19, 2024, 10:12 |
Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 19, 2024, 09:49 |
Blog
Zouina Sarfraz: We examined survival outcomes for Stage IV gastric cancer patients with Krukenberg tumors
Zouina Sarfraz, Associate Editor at European Journal of Medical Research, shared a post on LinkedIn: "I'm…
May 18, 2024, 09:06 |
Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 18, 2024, 08:33 |
Blog
Rami Manochakian: Results of Checkmate 77T trial of
Rami Manochakian shared a post on X/Twitter: ''Hot Off The Press. Just published at NEJM.…
May 18, 2024, 01:12 |
Opinion
Results from the IMpassion132 trial presented at ESMO Breast 24
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “Results from the IMpassion132 trial presented…
May 17, 2024, 13:16 |
Blog
Ciara C. O'Sullivan of Mayo Clinic, leads the Alliance A011801 trial - Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology shared on LinkedIn: “For Trial Tuesday, Ciara C. O'Sullivan,…
May 16, 2024, 08:20 |
Cancer Types
Neuroblastoma: What patients should know about
What is Neuroblastoma? Neuroblastoma is a type of cancer that originates in early nerve cells,…
May 15, 2024, 14:44 |
Blog
Maria Babak: Welcome to our May edition of Babak Monthly!
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 15, 2024, 13:45 |
Blog
Sergio Cifuentes Canaval: Exciting insights from the MRI-guided optimization study in HER2+ breast cancer!
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared a post on LinkedIn:…
May 15, 2024, 04:12 |
Blog
Tanja Obradovic: News about effectiveness of PD-1 inhibitors in endometrial cancer continues to paint complex picture
Tanja Obradovic shared on LinkedIn: ''News about effectiveness of PD-1 inhibitors in endometrial cancer continues…
May 14, 2024, 16:10 |
Blog
Luis E. Raez: Unfortunatly adding IO to chemo/radiation is not working but we have other options
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post by Patrick Forde, Co-Director of…
May 14, 2024, 14:59 |
Blog
Annals of Oncology March 2024 issue article of the month
Annals of Oncology shared a post by Annals of Oncology on X/Twitter, adding: ''The article…
May 13, 2024, 06:07 |
Blog
Mikkael A. Sekeres: Ending Oncology's Toxic Relationship With High Chemotherapy Doses
Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared a post…
May 12, 2024, 00:49 |
Insight
UCLA: Combination of breast cancer and chemotherapy may significantly speed up physical decline in older adults, by Mina Sedrak et al.
UCLA-led study by Mina Sedrak et al. suggests that one in three older patients who…
May 11, 2024, 13:57 |
Blog
Michelle Tucker’s inspiring story of becoming a nurse - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Michelle Tucker, BSN, RN, (right) wanted to be a nurse…
May 10, 2024, 08:10 |
Insight
The intricate world of copper-dependent pathways within tumor cells - The Babak Lab
Maria Babak, Assistant Professor at City University of Hong Kong, shared a post by The Babak…
May 8, 2024, 13:12 |
Blog
Hil Moss: Five-year mark of the hormone therapy
Hil Moss, Co-Founder/CEO of VivorCare, shared on LinkedIn: "This morning, I hit a milestone in…
May 8, 2024, 07:02 |
Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 7, 2024, 15:08 |
Blog
Stephen Liu: Dr. Yi-Long Wu discusses adjuvant EGFR targeted therapy at RomeLung24
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: "Dr.…
May 7, 2024, 11:33 |
Blog
Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by Jaime Grund, Director of St. Elizabeth Healthcare, on LinkedIn: "Patients are safer…
1
2
All:
178
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube